SNN
Smith & Nephew plcNYSEHealthcare$32.13+0.14%ClosedMarket Cap: $13.66B
As of 2026-04-06
Valuation
P/E (TTM)
13.16
PEG
0.12
P/B
2.61
P/S
2.15
EV/EBITDA
10.12
DCF Value
$28.78
FCF Yield
6.3%
Div Yield
2.4%
Margins & Returns
Gross Margin
68.0%
Operating Margin
16.3%
Net Margin
10.1%
ROE
11.8%
ROA
9.9%
ROIC
9.1%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $3.19B | 65.6% | $570.5M | $330.8M | $0.76 | $0.29 |
| FY 2025 | $6.18B | 68.0% | $1.01B | $626.5M | $1.44 | $0.75 |
| Q2 2025 | $2.99B | 70.6% | $434.9M | $295.6M | $0.68 | $0.46 |
| Q4 2024 | $2.98B | 69.5% | $329.0M | $198.0M | $0.46 | $0.29 |
| FY 2024 | $5.81B | 69.6% | $657.0M | $412.0M | $0.94 | $0.75 |
| Q2 2024 | $2.83B | 69.8% | $328.0M | $214.0M | $0.50 | $0.46 |
| Q4 2023 | $2.81B | 70.8% | $407.0M | $91.0M | $0.21 | $0.29 |
| FY 2023 | $5.55B | 68.8% | $425.0M | $263.0M | $1.20 | $0.75 |
| Q2 2023 | $2.73B | 69.4% | $275.0M | $172.0M | $0.39 | $0.46 |
| Q4 2022 | $2.62B | 71.4% | $423.0M | $46.0M | $0.11 | $0.28 |
| FY 2022 | $5.21B | 70.5% | $315.0M | $223.0M | $0.50 | $0.73 |
| Q2 2022 | $2.60B | 70.3% | $242.0M | $177.0M | $0.40 | $0.45 |